Comparing stent and non-stent treatments for peripheral arterial disease in a patient registry
Compares stent and non-stent treatments in people with peripheral arterial disease.
Key facts
- Who runs it
- Baylor Research Institute
- Where
- Atlanta, Austin, Boston, Chicago, Cleveland, Corpus Christi, Dallas, Davenport, Denver, Detroit, El Paso, Kingsport, Little Rock, McKinney, Muncie, New Bern, Oklahoma City, Philadelphia, San Antonio, and St Louis, United StatesSee the 24 sites
- Trial code
- Registry title
- Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
- Status
- Recruiting
- People taking part
- 14,000 people, planned
- Started
- Jan 2013
- Expected to end
- Jan 2033
- Type of study
- Observational, 2 groups
- Record updated
- 6 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with peripheral arterial disease (narrowed leg arteries) who had a procedure inside the artery through a thin tube. It compares results with and without stents.
- Sex
- All sexes can join.
- Disease stage
- Peripheral arterial disease treated in the iliac, common or superficial femoral, popliteal, peroneal, anterior tibial, or posterior tibial arteries.
- Earlier treatment
- People must have had an endovascular intervention (a treatment done inside the artery through a thin tube). People who had a surgical bypass cannot join.
Main reasons for not taking part
- Surgical bypass
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Underwent Endovascular Intervention
- Treated Iliac, Common or Superficial Femoral, Popliteal, Peroneal, Anterior Tibial, or Posterior Tibial Arteries
Who cannot take part
- Surgical Bypass
Where in United States
- Emory UniversityAtlanta, United StatesContact: David Fernandez Vazquez, MDNo longer taking part
- Seton Heart Institute/ UT AustinAustin, United StatesContact: Sarah J BenedictTaking people
- Cardiothoracic and Vascular SurgeonsAustin, United StatesContact: David Fernandez Vazquez, MDNo longer taking part
- VA Boston Healthcare SystemBoston, United StatesContact: David Fernandez Vazquez, MDNo longer taking part
- Loyola University Medical CenterChicago, United StatesContact: David Fernandez Vazquez, MDNo longer taking part
- Cleveland ClinicCleveland, United StatesContact: Aravinda Nanjundappa, MD (principal investigator)Taking people
- Harrington Heart and Vascular Institute, University HospitalsCleveland, United StatesContact: Mehdi Shishehbor, MD (principal investigator)Taking people
- Christus Sphon Hospital Corpus Christi-ShorelineCorpus Christi, United StatesContact: David Fernandez Vazquez, MDNo longer taking part
- Baylor Scott & White Research InstituteDallas, United StatesContact: David Fernandez Vazquez, MDTaking people
- North Texas Veteran Affairs Medical CenterDallas, United StatesContact: Shirling Tsai, MD (principal investigator)Taking people
- Mid West Cardiovascular Research FoundationDavenport, United StatesContact: David Fernandez Vazquez, MDNo longer taking part
- Denver VAMCDenver, United StatesContact: David Fernandez Vazquez, MDNo longer taking part
- Detroit Medical CenterDetroit, United StatesContact: Chadi Alraies, MD (principal investigator)Taking people
- El Paso Cardiovascular CareEl Paso, United StatesContact: David Fernandez Vazquez, MDNo longer taking part
- Wellmont CVA Heart InstituteKingsport, United StatesContact: Gaurav Rana, MD (principal investigator)Taking people
- Arkansas Heart InstituteLittle Rock, United StatesContact: David Fernandez Vazquez, MDNo longer taking part
- North Dallas Research AssociatesMcKinney, United StatesContact: David Fernandez Vazquez, MDNo longer taking part
- Indiana University Health Ball Memorial HospitalMuncie, United StatesContact: David Fernandez Vazquez, MDNo longer taking part
- Carolina East Health SystemNew Bern, United StatesContact: David Fernandez Vazquez, MDNo longer taking part
- Integris Heart HospitalOklahoma City, United StatesContact: David Fernandez Vazquez, MDNo longer taking part
- Oklahoma University Health Science CenterOklahoma City, United StatesContact: David Fernandez Vazquez, MDNo longer taking part
- Albert Einstein Healthcare NetworkPhiladelphia, United StatesContact: David Fernandez Vazquez, MDNo longer taking part
- UT Health Sciences CenterSan Antonio, United StatesContact: David Fernandez Vazquez, MDNo longer taking part
- St. Louis University Medical CenterSt Louis, United StatesContact: David Fernandez Vazquez, MDNo longer taking part
About the trial
What the trial wants to find out
XLPAD is an observational study designed to evaluate the effectiveness and use of stent and non-stent based therapies among PAD patients. The study will create a registry that will include entry of procedural and clinical follow-up information into an online data collection software, REDCAP.Data available since Jan 1 2005 will be included in the registry, until 14,000 patients have been included. The primary objectives of this observational registry study are to:
Read full original descriptionShow less
1. Compare stent and non-stent based outcomes defined as a composite of symptom driven target vessel revascularization (TVR), unplanned surgical revascularization of the target limb and need for target limb amputation through 12 months post-index procedure (Primary efficacy endpoint) 2. Compare stent and non-stent based outcomes defined as a composite of causes such as: death, myocardial infarction (MI), stroke, peri-procedural complications, target vessel revascularization (TVR) and unplanned surgical revascularization/amputation of the target limb through 12 months (Primary safety endpoint) 3. Compare stent and non-stent based change in walking distance, Rutherford category and/or ankle- brachial index (ABI) at 12 months compared to baseline (Primary clinical improvement endpoint)
Approximately 14,000patients will be enrolled at approximately 60 sites worldwide. Enrollment in the observational study will be monitored in an effort to achieve at least 20% (and no more than 80%) of the population receiving stents as the initial treatment strategy. Follow-up visits by sites will be reported at 6 and 12 months after index procedure to collect data on treatment patterns and effectiveness, and outcomes. The follow-up procedures are not mandated by the registry protocol. Each site will be encouraged to enter follow-up information derived from clinically indicated follow-up visits. All events post-index procedure till the 7th month will be reported under the 6 month follow-up form and subsequent follow-up till the 13th month post-procedure will be entered on the 12 month follow-up form.
Patient management and treatment decisions are at the discretion of the care team per routine clinical practice. The procedural aspects (including selection of stent type or non-stent based treatments) and follow-up are not mandated by the registry and will be up to the discretion of the operator and/or based upon the practice dictated by the clinical care of the patient. Therefore the study poses minimal risk to the patient.
The 2 groups in the trial
- Stent
The patient received one or more stents to the superficial femoral, popliteal, peroneal, anterior tibial, or posterior tibial arteries in AT LEAST one of the lesions treated during the course of the procedure.
- Non-Stent
The patient did not receive a stent to the superficial femoral, popliteal, peroneal, anterior tibial, or posterior tibial arteries in ANY of the lesions treated during the course of the procedure.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Multi-Center Registry Comparing Stent and Non-Stent Based Interventional Outcomes for Patients With Peripheral Arterial Disease
- Plain-language title
- Comparing stent and non-stent treatments for peripheral arterial disease in a patient registryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Publications
- Differences Between Patients With Intermittent Claudication and Critical Limb Ischemia Undergoing Endovascular Intervention: Insights From the Excellence in Peripheral Artery Disease Registry.Circulation. Cardiovascular interventions, 2021
- Comparative Outcomes of Supera Interwoven Nitinol vs Bare Nitinol Stents for the Treatment of Femoropopliteal Disease: Insights From the XLPAD Registry.Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 2020
- Adjunctive stent use during endovascular intervention to the femoropopliteal artery with drug coated balloons: Insights from the XLPAD registry.Vascular medicine (London, England), 2018
- Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 2017
- Comparative Assessment of Procedure Cost and Outcomes Between Guidewire and Crossing Device Strategies to Cross Peripheral Artery Chronic Total Occlusions.JACC. Cardiovascular interventions, 2016
- Femoropopliteal Artery Stent Thrombosis: Report From the Excellence in Peripheral Artery Disease Registry.Circulation. Cardiovascular interventions, 2016
- Record updated
- 6 February 2026